Haier Biomedical Strengthens European Commitment with Rome Summit

Haier Biomedical has reinforced its focus on the European market during its European Partner Summit held in Rome. The meeting, themed "Advancing Together - Sharing the Future of Biomedical Innovation," saw the participation of 37 partners and leaders from 23 countries. The company highlighted a strategic shift towards scenario-based solutions and reiterated its long-term commitment to Europe.

Enrique Wang, Global Market Director, emphasized Europe's key role in Haier's globalization strategy, aiming for over 50% of global revenue from international markets by 2027. The summit also showcased Haier's expansion from refrigerated solutions to full laboratory solutions, enhancing its product portfolio to include plasma apheresis systems and automation solutions.

New introductions, like the Plasma Apheresis System XJ-III, have secured EU MDR certification, demonstrating compliance with stringent regulations. Additionally, Haier's efforts in intelligent automation were highlighted, addressing market needs in sample integrity and efficient management.